Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.22 AUD 4.76% Market Closed
Market Cap: 121.3m AUD
Have any thoughts about
Medadvisor Ltd?
Write Note

Medadvisor Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medadvisor Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Medadvisor Ltd
ASX:MDR
Cash & Cash Equivalents
AU$15.6m
CAGR 3-Years
30%
CAGR 5-Years
29%
CAGR 10-Years
45%
Mach7 Technologies Ltd
ASX:M7T
Cash & Cash Equivalents
AU$26.2m
CAGR 3-Years
13%
CAGR 5-Years
63%
CAGR 10-Years
47%
4DMedical Ltd
ASX:4DX
Cash & Cash Equivalents
AU$30.6m
CAGR 3-Years
-28%
CAGR 5-Years
58%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Cash & Cash Equivalents
$30.1m
CAGR 3-Years
8%
CAGR 5-Years
56%
CAGR 10-Years
41%
Pro Medicus Ltd
ASX:PME
Cash & Cash Equivalents
AU$60.1m
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
16%
Medibio Ltd
ASX:MEB
Cash & Cash Equivalents
AU$214.1k
CAGR 3-Years
-36%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
No Stocks Found

Medadvisor Ltd
Glance View

Market Cap
121.1m AUD
Industry
Health Care

MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..

MDR Intrinsic Value
0.28 AUD
Undervaluation 21%
Intrinsic Value
Price

See Also

What is Medadvisor Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
15.6m AUD

Based on the financial report for Jun 30, 2024, Medadvisor Ltd's Cash & Cash Equivalents amounts to 15.6m AUD.

What is Medadvisor Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
45%

Over the last year, the Cash & Cash Equivalents growth was 10%. The average annual Cash & Cash Equivalents growth rates for Medadvisor Ltd have been 30% over the past three years , 29% over the past five years , and 45% over the past ten years .

Back to Top